Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,955.20
(
0.32%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
91.46
(
0.86%
)
Bitcoin
76,409.21
(
0.68%
)
News Focus
News Focus
Post# of 517462
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

gerry57

Send PM Follow Ignore
Followers 0
Posts 250
Boards Moderated 0
Alias Born 08/09/2017

gerry57

Re: boi568 post# 483424

Wednesday, 02/19/2025 3:49:05 PM

Wednesday, February 19, 2025 3:49:05 PM

Post# of 517462
Actually you have touched upon an aspect I was just wondering about. Investor is saying each application stands on its merits and blarcamesine might not have the attributes necessary to fall into the90% group of approved drugs at this stage , which means I think it must have something in common with the failed treatments, what in the world could that be?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News